| abstract |
The present invention is an orally consumed fixed combination formulation of both atorvastatin and ezetimibe in one tablet that is expected to have same Area Under Curve as two active ingredients taken together individually orally, and pharmaceutically acceptable additives suitable for the preparation. In preferred embodiments of this invention, the atorvastatin is in the form of atorvastatin calcium and the pharmaceutically acceptable additives are selected from the diluents, disintegrants, glidants, lubricants, colorants and combinations thereof. |